Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Unaudited)

v3.24.3
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2022 $ 104,520   $ 270,129 $ (47) $ (165,562)
Beginning balance, Shares at Dec. 31, 2022   29,445,134      
Stock-based compensation 2,480   2,480    
Net unrealized losses on available-for-sale securities 47     47  
Issuance of common stock in connection with exercise of stock options 458   458    
Issuance of common stock in connection with exercise of stock options, Shares   84,264      
Issuance of common stock upon exercise of pre-funded warrants, Shares   1,811,591      
Net Income (Loss) (15,854)       (15,854)
Ending balance at Mar. 31, 2023 91,651   273,067   (181,416)
Ending balance, Shares at Mar. 31, 2023   31,340,989      
Beginning balance at Dec. 31, 2022 104,520   270,129 (47) (165,562)
Beginning balance, Shares at Dec. 31, 2022   29,445,134      
Net Income (Loss) (46,789)        
Ending balance at Sep. 30, 2023 160,923   373,295 (21) (212,351)
Ending balance, Shares at Sep. 30, 2023   41,660,169      
Beginning balance at Dec. 31, 2022 104,520   270,129 (47) (165,562)
Beginning balance, Shares at Dec. 31, 2022   29,445,134      
Ending balance at Dec. 31, 2023 $ 236,198   469,396 39 (233,237)
Ending balance, Shares at Dec. 31, 2023 47,823,232 47,823,232      
Beginning balance at Mar. 31, 2023 $ 91,651   273,067   (181,416)
Beginning balance, Shares at Mar. 31, 2023   31,340,989      
Stock-based compensation 2,803   2,803    
Common stock issuance 93,755   93,755    
Common stock issuance, Shares   8,337,500      
Net unrealized losses on available-for-sale securities (3)     (3)  
Issuance of common stock in connection with exercise of stock options 390   390    
Issuance of common stock in connection with exercise of stock options, Shares   107,122      
Issuance of common stock under employee stock purchase plan 32   32    
Issuance of common stock under employee stock purchase plan, shares   8,071      
Net Income (Loss) (14,487)       (14,487)
Ending balance at Jun. 30, 2023 174,141   370,047 (3) (195,903)
Ending balance, Shares at Jun. 30, 2023   39,793,682      
Stock-based compensation 3,009   3,009    
Net unrealized losses on available-for-sale securities (18)     (18)  
Issuance of common stock in connection with exercise of stock options 239   239    
Issuance of common stock in connection with exercise of stock options, Shares   81,640      
Issuance of common stock upon exercise of pre-funded warrants, Shares   1,784,847      
Net Income (Loss) (16,448)       (16,448)
Ending balance at Sep. 30, 2023 160,923   373,295 (21) (212,351)
Ending balance, Shares at Sep. 30, 2023   41,660,169      
Beginning balance at Dec. 31, 2023 $ 236,198   469,396 39 (233,237)
Beginning balance, Shares at Dec. 31, 2023 47,823,232 47,823,232      
Stock-based compensation $ 3,791   3,791    
Common stock issuance 5,746   5,746    
Common stock issuance, Shares   258,070      
Net unrealized losses on available-for-sale securities (77)     (77)  
Issuance of common stock in connection with exercise of stock options 1,109   1,109    
Issuance of common stock in connection with exercise of stock options, Shares   167,813      
Net Income (Loss) (25,047)       (25,047)
Ending balance at Mar. 31, 2024 221,720   480,042 (38) (258,284)
Ending balance, Shares at Mar. 31, 2024   48,249,115      
Beginning balance at Dec. 31, 2023 $ 236,198   469,396 39 (233,237)
Beginning balance, Shares at Dec. 31, 2023 47,823,232 47,823,232      
Net Income (Loss) $ (83,278)        
Ending balance at Sep. 30, 2024 $ 174,241   490,755 1 (316,515)
Ending balance, Shares at Sep. 30, 2024 48,850,423 48,850,423      
Beginning balance at Mar. 31, 2024 $ 221,720   480,042 (38) (258,284)
Beginning balance, Shares at Mar. 31, 2024   48,249,115      
Stock-based compensation 5,013   5,013    
Net unrealized losses on available-for-sale securities 9     9  
Issuance of common stock in connection with exercise of stock options 250   250    
Issuance of common stock in connection with exercise of stock options, Shares   27,407      
Issuance of common stock under employee stock purchase plan 129   129    
Issuance of common stock under employee stock purchase plan, shares   14,947      
Net Income (Loss) (27,602)       (27,602)
Ending balance at Jun. 30, 2024 199,519   485,434 (29) (285,886)
Ending balance, Shares at Jun. 30, 2024   48,291,469      
Stock-based compensation 5,250   5,250    
Net unrealized losses on available-for-sale securities 30     30  
Issuance of common stock in connection with exercise of stock options 71   71    
Issuance of common stock in connection with exercise of stock options, Shares   15,475      
Issuance of common stock upon exercise of pre-funded warrants, Shares   543,479      
Net Income (Loss) (30,629)       (30,629)
Ending balance at Sep. 30, 2024 $ 174,241   $ 490,755 $ 1 $ (316,515)
Ending balance, Shares at Sep. 30, 2024 48,850,423 48,850,423